Project Grant R03CA304056
Award Date
7/16/25
Completion Date
6/30/27
Dollars Obligated
$164K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Tuscaloosa, AL 35487, USA
Similar Awards
This federal Project Grant award of $334,233, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support a comprehensive research study examining disparities in novel cancer therapies, the joint effects of cancer treatment and comorbidities, and multi-level contributors to cancer survival outcomes. The University of South Carolina, the prime awardee, will conduct innovative data linkages between the state cancer registry,...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $653,500.00 to Emory University to develop improved methods for measuring the completeness of cancer registries in the United States. The key products and services to be delivered under this 5-year grant include: Developing advanced statistical methods to estimate cancer registry completeness that account for factors such as cancer type, demographics, geography, and...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $192,489 to the University of Alabama at Birmingham (UAB) from February 1, 2025 to January 31, 2030. The project aims to evaluate the implementation and impact of oncology financial navigation, an evidence-based intervention to help cancer patients manage treatment-related financial hardship. Key activities include: Tracking implementation strategies and their effect on outcomes like...
The National Cancer Institute (NCI) awarded a $432,304 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The Trustees of Columbia University in the City of New York, Health Sciences Division. The grant, awarded on January 3, 2025, supports a 5-year research project focused on "Enhanced Cancer Risk Predictions in Underrepresented Populations through Robust Multi-Source Data Integration." The project aims to develop novel data integration methods to...
This Project Grant award of $661,845, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), will support a multi-year research project titled "Unpacking Structural Racism in Quality of End-of-Life Care for Children with Cancer." The primary awardee is the University of Alabama at Birmingham, which will collaborate with sub-awardees The University of Texas Southwestern Medical Center and Dana-Farber Cancer Institute to...
This federal Project Grant award of $505,613, provided by the National Cancer Institute (CFDA 93.394 Cancer Detection and Diagnosis Research), will support the development of statistical and computational approaches to harness genomic data and translate findings into precision prevention strategies for cancer. The key objectives are to: Develop deep learning-based methods to identify tumor subtypes linked to adverse outcomes and robust data integration approaches to assess associations between...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) for $231,710 will be used by Arizona State University (ASU) to develop and validate machine learning algorithms to assess microscale pedestrian environment features (PEFs) in rural areas. The goal is to understand the relationship between these microscale PEFs and physical activity levels among middle to older age adults in rural communities, and identify any disparities in PEFs by...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $714,062 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the biological mechanisms contributing to racial disparities in head and neck cancer outcomes, particularly among Black patients. The key objectives are to: 1) Develop a prognostic model using gene expression signatures to predict disease progression in early-stage oral squamous cell...
The National Cancer Institute (NCI) awarded a $831,565 Cooperative Agreement (CFDA 93.393 - Cancer Cause and Prevention Research) to the University of Massachusetts Medical School (UMass Medical) to develop an Integrative Analysis and Visualization Platform for Cancer Regulatory Genomics. The project aims to create a Regulatory-Element-Target-Gene Atlas that will enable researchers to explore connections between regulatory elements and genes associated with cancer. It will also perform...
This Project Grant award of $572,490.00 from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) will fund the development of PILLAR, an AI-based tool to predict breast cancer risk from longitudinal multi-modal breast imaging data. The project aims to create novel machine learning architectures and self-supervised learning algorithms to improve the accuracy of cancer risk assessment over current clinical models. Additionally, the project will develop methods...